Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
PLoS One ; 9(2): e89512, 2014.
Artigo em Inglês | MEDLINE | ID: mdl-24586837

RESUMO

The membrane of red blood cells consists of a phospholipid bilayer with embedded membrane proteins and is associated on the cytoplasmatic side with a network of proteins, the membrane skeleton. Band3 has an important role as centre of the functional complexes e.g. gas exchange complex and as element of attachment for the membrane skeleton maintaining membrane stability and flexibility. Up to now it is unclear if band3 is involved in the morphology change of red blood cells after contact with radiographic contrast media. The study revealed for the first time that Iopromide induced markedly more severe alterations of the membrane skeleton compared to Iodixanol whose effects were similar to erythrocytes suspended in autologous plasma. A remarkable clustering of band3 was found associated with an accumulation of band3 in spicules and also a sequestration of band3 to the extracellular space. This was evidently accompanied by a gross reduction of functional band3 complexes combined with a dissociation of spectrin from band3 leading to a loss of homogeneity of the spectrin network. It could be demonstrated for the first time that RCM not only induced echinocyte formation but also exocytosis of particles at least coated with band3.


Assuntos
Proteína 1 de Troca de Ânion do Eritrócito/metabolismo , Estruturas Celulares/efeitos dos fármacos , Meios de Contraste/farmacologia , Membrana Eritrocítica/efeitos dos fármacos , Eritrócitos/efeitos dos fármacos , Iohexol/análogos & derivados , Espectrina/metabolismo , Ácidos Tri-Iodobenzoicos/farmacologia , Estruturas Celulares/metabolismo , Membrana Eritrocítica/metabolismo , Eritrócitos/citologia , Eritrócitos/metabolismo , Humanos , Processamento de Imagem Assistida por Computador , Iohexol/farmacologia , Interpretação de Imagem Radiográfica Assistida por Computador
2.
Clin Hemorheol Microcirc ; 54(3): 235-48, 2013 Jan 01.
Artigo em Inglês | MEDLINE | ID: mdl-23603330

RESUMO

Linear, side-chain methylated oligoglycerols (OGMe) were recently reported as potential surface passivating molecules for improving the protein resistance of cardiovascular application relevant poly(ether imide) (PEI) membranes. A previously reported in vitro screening under static test conditions allowed an end-point evaluation of the adhesion and activation of adherent thrombocytes performed on the material surfaces and revealed similar levels of thrombogenicity on PEI membranes, functionalized with OGMe and oligo(ethylene glycol) (OEG) of similar molecular weight (Mn = 1,300 g·mol-1 - 1,800 g·mol-1). In the present study, we investigated the hemocompatibility of these materials in a dynamic closed loop system, in order to study time-dependent thrombocyte material interactions also of the circulating thrombocytes by mimicking in vivo relevant flow conditions in a dynamic test system with multiple material contacts. Activation and aggregation of circulating thrombocytes as well as complement activation and plasmatic coagulation were evaluated after 40 circulations of thrombocyte rich plasma in the closed loop system. The results of the dynamic tests revealed no differences between the OGMe and OEG functionalized PEI membranes. Furthermore, no differences were observed between the latter and a PEI membrane treated under the conditions of functionalization at pH 11 (PEI-pH11) without an oligoether being present. Blood plasma protein adsorption, as well as activation, and adherence of circulating thrombocytes occurred in a comparable, but minor manner on all investigated PEI membranes. From this we conclude that the OGMe and OEG surface functionalization did not lead to an improvement of the already good hemocompatibility of the PEI-pH11 membrane.


Assuntos
Materiais Biocompatíveis/metabolismo , Coagulação Sanguínea/efeitos dos fármacos , Glicerol/metabolismo , Membranas Artificiais , Polietilenoglicóis/metabolismo , Polímeros/metabolismo , Materiais Biocompatíveis/química , Plaquetas/citologia , Plaquetas/efeitos dos fármacos , Ativação do Complemento/efeitos dos fármacos , Glicerol/química , Humanos , Teste de Materiais , Metilação , Ativação Plaquetária/efeitos dos fármacos , Polietilenoglicóis/química , Polímeros/química , Propriedades de Superfície
3.
Cardiovasc Res ; 75(3): 596-607, 2007 Aug 01.
Artigo em Inglês | MEDLINE | ID: mdl-17531214

RESUMO

OBJECTIVE: Flow-induced conversion of endothelial cells into an elongated arterial phenotype requires a coordinated regulation of cell junctions. Here we investigated the effect of acute and chronic flow on junction regulation. METHODS AND RESULTS: Using an extended experimental setup that allows analyses of endothelial barrier function under flow conditions, we found a flow-induced upregulation of the transendothelial electrical resistance within minutes. This was accompanied by an increase in actin filaments along the junctions and vascular endothelial (VE)-cadherin clustering, which was identified at nanoscale resolution by stimulated emission depletion microscopy. In addition, a transient tyrosine phosphorylation of VE-cadherin and catenins occurred within minutes following the onset of flow. VE-cadherin and actin distribution were maintained under chronic flow over 24 h and associated with the upregulation of VE-cadherin and alpha-catenin expression, thus compensating for the cell elongation-mediated increase in cell border length. Importantly, all observed effects were rac1 dependent as verified by the inhibitory effect of dominant negative N17rac1. CONCLUSION: These results show that flow-induced conversion of endothelial cells into an arterial phenotype occurs while intercellular junctions remain intact. The data place rac1 in a central multimodal regulatory position that might be important in the development of vascular diseases, such as arteriosclerosis.


Assuntos
Células Endoteliais/metabolismo , Junções Intercelulares/metabolismo , Actinas/metabolismo , Antígenos CD/metabolismo , Artérias , Caderinas/metabolismo , Adesão Celular , Membrana Celular/metabolismo , Permeabilidade da Membrana Celular , Células Cultivadas , Eletrofisiologia , Humanos , Microscopia Eletrônica , Microscopia de Fluorescência , Fenótipo , Fosforilação , Fluxo Sanguíneo Regional , Estresse Mecânico , Veias , Proteínas rac1 de Ligação ao GTP/metabolismo , Proteínas rho de Ligação ao GTP/metabolismo
4.
Semin Thromb Hemost ; 31(4): 464-9, 2005.
Artigo em Inglês | MEDLINE | ID: mdl-16149025

RESUMO

In 1974, Wu and Hoak described a method for determining circulating platelet aggregates. This method was modified by Grotemeyer in 1983. The platelet reactivity index (PR) is based on the ratio of platelet aggregates in blood samples obtained in different buffer solutions. Platelet aggregates are resolved when blood is sampled in EDTA-buffer, but remain fixed when EDTA-formalin-buffer is used. Generally, the PR is preferred, because in vitro manipulations of platelets are not necessary, and the results are calculated. PR values above 1.05 are suspicious for elevated platelet aggregation. PR values above 1.2 indicate pathological changes in platelet aggregation. The PR is inexpensive (4.0 euro dollars) and rapid to perform. PR values were used successfully to identify nonresponders to secondary prophylaxis with acetylsalicylic acid (ASA), that is, patients suffering from stroke (33%) and patients after cardiac ischemia (18%). Furthermore, elevated PR values correlated significantly with the incidence of arterial thromboembolic complications. The PR correlated well in our prospective study with values received from the retention test Homburg (RT-H) and the platelet function analyzer (PFA-100). The data indicate that the values of the PR seem to be highly predictive for the evaluation of the ASA therapy. However, the PR is not feasible for the determination of the ASA overdosage.


Assuntos
Plaquetas/efeitos dos fármacos , Monitoramento de Medicamentos/métodos , Inibidores da Agregação Plaquetária/farmacologia , Testes de Função Plaquetária/métodos , Aspirina/farmacologia , Ensaios Clínicos como Assunto , Ácido Edético/farmacologia , Feminino , Citometria de Fluxo , Formaldeído/farmacologia , Humanos , Ativação Plaquetária , Adesividade Plaquetária , Agregação Plaquetária , Contagem de Plaquetas , Testes de Função Plaquetária/economia , Testes de Função Plaquetária/instrumentação , Gravidez , Estudos Prospectivos , Tromboembolia , Fatores de Tempo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...